Members of the billionaire Sackler family that own Purdue Pharma LP are close to a deal to increase their contribution to the OxyContin maker’s sweeping opioid settlement, court papers show.
The family and a handful of state attorneys general that have been opposing Purdue’s opioid settlement are nearing a deal that would provide a “substantial” additional contribution on top of the $4.325 billion the company’s owners already pledged, according to the court documents.
The potential deal follows mediation sessions that spanned 100 phone calls and two lengthy in-person gatherings.
